OCQUILA

USPTO USPTO 2009 CANCELLED - SECTION 8

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die US-Marke OCQUILA wurde als Wortmarke am 19.02.2009 beim Amerikanischen Patent- und Markenamt angemeldet.
Sie wurde am 26.04.2011 im Markenregister eingetragen. Der aktuelle Status der Marke ist "CANCELLED - SECTION 8".

Markendetails Letztes Update: 17. August 2019

Markenform Wortmarke
Aktenzeichen 77673792
Registernummer 3949710
Anmeldedatum 19. Februar 2009
Veröffentlichungsdatum 08. Februar 2011
Eintragungsdatum 26. April 2011

Markeninhaber

Medawar Centre, Robert Robinson Avenue
OX44GA Oxford
GB

Markenvertreter

Waren und Dienstleistungen

1 Chemicals for use in industry and science; enzymes for scientific and research purposes; biochemicals, namely, precursors for in vitro genetic engineering use; biochemicals, namely, polypeptides for in vitro research use; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; chemicals for use in the purification of proteins for in vitro use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; micro-organisms for laboratory and scientific research use, viruses for laboratory and scientific research use, cell cultures for laboratory and scientific research use, plasmids and cultures of micro-organisms for laboratory and scientific research use, nucleic acid sequences for laboratory and scientific research use, cloning vehicles in the nature of plasmids, microbes and chemical reagents for DNA cloning for laboratory and scientific research use, chemicals for laboratory and scientific research and development use in biotechnology research and development and recombinant nucleic acid variations thereof for laboratory and scientific research use, all of the foregoing for in-vivo use
5 Gene therapy and prophylactic products, namely, gene delivery pharmaceuticals; small molecules, vaccines, biologics, enzymes and enzyme preparations all for medical purposes in connection with gene therapy, pharmaceuticals for medical purposes for the delivery of genes to cells; viral, retroviral and non-viral vectors, and manufacturing preparations for viral, retroviral and non-viral vectors, all for medical purposes in gene therapy; biochemical and chemical preparations for medical purposes in gene therapy; pharmaceutical and biochemical preparations for the treatment or prevention of cancer, infectious disease, fungal diseases, disease caused by parasites, eye disease, diseases of the central and peripheral nervous systems, cardiovascular disease, diseases affecting the immune system, inflammatory diseases, inherited disease, single gene disorders, diseases of the mouth, teeth, skin, hair and ear, bone and blood diseases and reproductive system disorders; pharmaceutical and biochemical preparations for contraceptive purposes
10 Instruments and apparatus for the administration of pharmaceutical, gene therapy and/or vaccine preparations and substances, namely, pre-filled vials, syringes and injectors for medical purposes
42 Scientific, pharmaceutical and medical research and development; genetic engineering services, biotechnology services, namely, research and development of new products in the field of biotechnology, advisory services relating to the research and development of gene therapy products and clinical trials, conducting clinical trials
44 Medical services; advisory services relating to vaccination regimens; advisory services relating to the treatment, relief and/or prevention of cancer, infectious diseases, fungal diseases, disease caused by parasites, eye disease, diseases of the central and peripheral nervous systems, cardiovascular disease, diseases affecting the immune system, inflammatory diseases, inherited disease, single gene disorders, diseases of the mouth, teeth, skin, hair and ear, bone and blood diseases, reproductive system disorders, in humans and animals, and advisory services relating to the use of pharmaceutical and biochemical preparations for contraceptive purposes, in humans and animals
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

ID: 1377673792